A detailed history of Caxton Associates LP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Caxton Associates LP holds 75,848 shares of ADMA stock, worth $1.34 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
75,848
Previous 206,727 63.31%
Holding current value
$1.34 Million
Previous $2.31 Million 34.4%
% of portfolio
0.06%
Previous 0.08%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $1.47 Million - $2.62 Million
-130,879 Reduced 63.31%
75,848 $1.52 Million
Q2 2024

Aug 14, 2024

SELL
$5.98 - $11.18 $1.09 Million - $2.04 Million
-182,464 Reduced 46.88%
206,727 $2.31 Million
Q1 2024

May 15, 2024

BUY
$4.4 - $6.74 $1.63 Million - $2.49 Million
369,498 Added 1876.29%
389,191 $2.57 Million
Q4 2023

Feb 14, 2024

BUY
$3.08 - $4.52 $60,654 - $89,012
19,693 New
19,693 $89,000
Q2 2023

Aug 14, 2023

SELL
$3.12 - $4.22 $201,954 - $273,156
-64,729 Reduced 31.59%
140,190 $517,000
Q1 2023

May 15, 2023

SELL
$3.01 - $3.87 $91,070 - $117,090
-30,256 Reduced 12.87%
204,919 $678,000
Q4 2022

Feb 14, 2023

BUY
$2.47 - $3.88 $580,882 - $912,479
235,175 New
235,175 $912,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.48B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.